Aiming for better glucose control: is HbA1c of 7% the 'holy grail'? The clinical approach or seven clinical questions about 7. Issue 5 (July 2014)

• Record Type: Journal Article
• Authors: Koren, Shlomit; Rapoport, Micha J.
• Is Part Of: Diabetes/metabolism research and reviews. Volume 30:Issue 5(2014:Jul.)
• Page Start: 346
• Page End: 349
• Publication Date: 2014-07
• Subjects: Diabetes -- Periodicals; Metabolism -- Periodicals; 616.642
• DOI: 10.1002/dmrr.2532
• Languages: English
• ISSNs: 1520-7552

Abstract

<abstract abstract-type="main"> <title>Summary</title> <p>The diabetes epidemic imposes a substantial burden on health systems and economy all over the world. Over the last two decades, many health systems adopted health care quality and performance measures for diabetes mellitus, most notably haemoglobin A_1c. This article raises concerns regarding the significance of HbA_1c as a performance measure and emphasizes the need for individualized therapy. Copyright © 2014 John Wiley &amp; Sons, Ltd.</p> </abstract>